Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Robert

Showing results (341-350 of 349) with videos related to

Pageof 35
Sort By:
You have reached the last page of results.This site can display upto 349 results.
The Lancet. Neurology|April 1, 2017
Effect of long-term omega 3 polyunsaturated fatty acid supplementation with or without multidomain intervention on cognitive function in elderly adults with memory complaints (MAPT): a randomised, placebo-controlled trialSandrine Andrieu, Sophie Guyonnet, Nicola Coley, et al.
The Lancet. Neurology|October 12, 2010
Revising the definition of Alzheimer's disease: a new lexiconBruno Dubois, Howard H Feldman, Claudia Jacova, et al.
BMJ Open|June 27, 2019
How many patients are eligible for disease-modifying treatment in Alzheimer's disease? A French national observational study over 5 yearsStéphane Epelbaum, Claire Paquet, Jacques Hugon, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 5, 2021
Diagnostic criteria for apathy in neurocognitive disordersDavid S Miller, Philippe Robert, Larry Ereshefsky, et al.
Frontiers in Psychology|August 10, 2017
Recommendations for the Use of Serious Games in Neurodegenerative Disorders: 2016 Delphi PanelValeria Manera, Grégory Ben-Sadoun, Teun Aalbers, et al.
Current Alzheimer Research|June 25, 2005
JLK inhibitors: isocoumarin compounds as putative probes to selectively target the gamma-secretase pathwayFrédéric Checler, Checler Frédéric, Cristine Alves da Costa, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 21, 2022
Plasma amyloid beta predicts conversion to dementia in subjects with mild cognitive impairment: The BALTAZAR studyOlivier Hanon, Jean-Sébastien Vidal, Sylvain Lehmann, et al.
The Lancet. Neurology|May 23, 2014
Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteriaBruno Dubois, Howard H Feldman, Claudia Jacova, et al.
International Journal of Geriatric Psychiatry|October 29, 2019
Pathways to care for people with dementia: An international multicentre studyUmberto Volpe, Hania Amin, Olatunde O Ayinde, et al.
Pageof 35

Showing results (341-350 of 349) with videos related to

Sort By:
Pageof 35
You have reached the last page of results.This site can display upto 349 results.
The Lancet. Neurology|April 1, 2017
Effect of long-term omega 3 polyunsaturated fatty acid supplementation with or without multidomain intervention on cognitive function in elderly adults with memory complaints (MAPT): a randomised, placebo-controlled trialSandrine Andrieu, Sophie Guyonnet, Nicola Coley, et al.
The Lancet. Neurology|October 12, 2010
Revising the definition of Alzheimer's disease: a new lexiconBruno Dubois, Howard H Feldman, Claudia Jacova, et al.
BMJ Open|June 27, 2019
How many patients are eligible for disease-modifying treatment in Alzheimer's disease? A French national observational study over 5 yearsStéphane Epelbaum, Claire Paquet, Jacques Hugon, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 5, 2021
Diagnostic criteria for apathy in neurocognitive disordersDavid S Miller, Philippe Robert, Larry Ereshefsky, et al.
Frontiers in Psychology|August 10, 2017
Recommendations for the Use of Serious Games in Neurodegenerative Disorders: 2016 Delphi PanelValeria Manera, Grégory Ben-Sadoun, Teun Aalbers, et al.
Current Alzheimer Research|June 25, 2005
JLK inhibitors: isocoumarin compounds as putative probes to selectively target the gamma-secretase pathwayFrédéric Checler, Checler Frédéric, Cristine Alves da Costa, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 21, 2022
Plasma amyloid beta predicts conversion to dementia in subjects with mild cognitive impairment: The BALTAZAR studyOlivier Hanon, Jean-Sébastien Vidal, Sylvain Lehmann, et al.
The Lancet. Neurology|May 23, 2014
Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteriaBruno Dubois, Howard H Feldman, Claudia Jacova, et al.
International Journal of Geriatric Psychiatry|October 29, 2019
Pathways to care for people with dementia: An international multicentre studyUmberto Volpe, Hania Amin, Olatunde O Ayinde, et al.
Pageof 35